Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.

Multiple methods, pedigree analysis, clinical evaluation, and Epstein-Barr virus (EBV)-specific serology, EBV DNA hybridization of tissues to probe for viral genome, staining of touch imprints for EBV nuclear-associated antigen, establishment of spontaneous infected B-cell lines from peripheral blood or tissues, examination of peripheral blood smears, and hematopathology studies, were used to study seven patients with the X-linked lymphoproliferative syndrome and seven additional patients with life-threatening EBV-associated diseases. These studies demonstrated EBV in the tissues of all 14 patients and immunodeficient antibody responses to EBV were documented. This virus can produce various life-threatening lymphoproliferative diseases in a variety of immunodeficient patients.

[1]  J. Najarian,et al.  Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. , 1981, Cancer research.

[2]  M. Anvret,et al.  Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. , 1981, Cancer research.

[3]  D. Purtilo,et al.  Antibodies to epstein‐barr virus‐specific antigens in patients with hairy‐cell leukemia , 1981, International journal of cancer.

[4]  D. Purtilo.  X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma. , 1981, Archives of pathology & laboratory medicine.

[5]  D. Purtilo,et al.  Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. , 1980, Journal of immunology.

[6]  K. Clausen,et al.  X-linked lymphoproliferative syndrome registry report. , 1980, The Journal of pediatrics.

[7]  D. Purtilo.  EPSTEIN-BARR-VIRUS-INDUCED ONCOGENESIS IN IMMUNE-DEFICIENT INDIVIDUALS , 1980, The Lancet.

[8]  B. Sugden,et al.  Epstein-Barr virus DNA is amplified in transformed lymphocytes , 1979, Journal of virology.

[9]  G. Klein.  Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Kieff,et al.  DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus , 1978, Journal of virology.

[11]  D. Thorley-Lawson,et al.  EPSTEIN-BARR VIRUS INFECTIONS IN THE X-LINKED RECESSIVE LYMPHOPROLIFERATIVE SYNDROME , 1978, The Lancet.

[12]  G. Klein,et al.  Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis. , 1978, The New England journal of medicine.

[13]  L. Podoshin,et al.  Familial lymphoma. , 1978, Ear, nose, & throat journal.

[14]  D. Purtilo,et al.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. , 1977, The New England journal of medicine.

[15]  T. Lindahl,et al.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. , 1976, Journal of molecular biology.

[16]  G. Vawter,et al.  X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE) , 1975, The Lancet.

[17]  G. Klein,et al.  Relationship between Epstein‐Barr virus (EBV) DNA and the EBV‐determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies , 1974, International journal of cancer.

[18]  W. Henle,et al.  Fatal infectious mononucleosis in a family. , 1974, The New England journal of medicine.

[19]  W. Henle,et al.  Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. , 1974, Human pathology.

[20]  C. Heath,et al.  A fatal x-linked recessive reticuloendothelial syndrome with hyperglobulinemia. X-linked recessive reticuloendotheliosis. , 1973, The Journal of pediatrics.

[21]  G. Klein,et al.  Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.

[22]  J. Sambrook,et al.  Amount of viral DNA in the genome of cells transformed by adenovirus type 2. , 1973, Journal of molecular biology.

[23]  G. Klein,et al.  Demonstration of two distinct components in the early antigen complex of epstein‐barr virus‐infected cells , 1971, International journal of cancer.

[24]  W. Henle,et al.  Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus , 1970, Science.

[25]  W. Henle,et al.  Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.